Posted on September 6th, 2010 by Health News
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, cardiovascular disease and cancer, announces that the pooled results from the successful microplasmin MIVI-TRUST Phase III program were presented today at the EURETINA (European Society of Retina Specialists) Congress in Paris, France.
No Comments »
Filed under: Pharmacy News
Posted on September 6th, 2010 by Health News
Peter Mansell explores how effective concordance can take the strain off industry-patient group partnerships. Pharmaceutical companies and patient organizations are never going to be the easiest of fits. It is not so much due to any fundamental unwillingness to work together, or lack of common ground, but rather to the kind of attention these relationships [...]
No Comments »
Filed under: Pharmacy News
Posted on September 6th, 2010 by Health News
Nearly half of all Americans used at least one prescription drug per month in 2008, according to a study by the Centers for Disease Control and Prevention, Bloomberg reports. That’s a 10 percent increase over the preceding decade. Over that time, yearly spending by Americans on drugs doubled to $234 billion. “The two biggest-sellers last [...]
No Comments »
Filed under: Pharmacy News
Posted on September 6th, 2010 by Health News
Nearly half of all Americans used at least one prescription drug per month in 2008, according to a study by the Centers for Disease Control and Prevention, Bloomberg reports. That’s a 10 percent increase over the preceding decade. Over that time, yearly spending by Americans on drugs doubled to $234 billion. “The two biggest-sellers last [...]
No Comments »
Filed under: Pharmacy News
Posted on September 6th, 2010 by Health News
For the estimated 83,000 women who will be diagnosed with a gynecologic cancer in 2010, participation in clinical trials offers an opportunity both to ensure that future patients benefit from the most up-to-date treatments and increased survival rates and to potentially improve the health of current patients…
No Comments »
Filed under: Women's Health
